Bnp Paribas Asset Management Holding S.A. Agios Pharmaceuticals, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.6 Billion
Q1 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,108,613 shares of AGIO stock, worth $47.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,108,613

Previous 1,046,460 5.94%

Holding current value

$47.8 Million

Previous $23.3 Million 39.09%

% of portfolio

0.09%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$21.32 - $34.81 $1.33 Million - $2.16 Million	62,153 Added 5.94%	1,108,613 $32.4 Million
Q4 2023 Feb 09, 2024	BUY	$19.97 - $24.53 $879,818 - $1.08 Million	44,057 Added 4.4%	1,046,460 $23.3 Million
Q3 2023 Nov 13, 2023	BUY	$24.36 - $28.18 $1.81 Million - $2.09 Million	74,144 Added 7.99%	1,002,403 $24.8 Million
Q2 2023 Aug 08, 2023	SELL	$21.38 - $29.19 $2.1 Million - $2.87 Million	-98,328 Reduced 9.58%	928,259 $26.3 Million
Q1 2023 May 08, 2023	BUY	$21.74 - $30.93 $232,791 - $331,198	10,708 Added 1.05%	1,026,587 $23.6 Million

Q4 2022 Feb 09, 2023	BUY	$24.81 - $31.52 $2.24 Million - $2.85 Million	90,449 Added 9.77%	1,015,879 $28.5 Million
Q3 2022 Nov 10, 2022	BUY	$19.51 - $34.14 $594,508 - $1.04 Million	30,472 Added 3.4%	925,430 $26.2 Million
Q2 2022 Aug 04, 2022	SELL	$17.06 - $31.42 $1.07 Million - $1.98 Million	-62,972 Reduced 6.57%	894,958 $19.8 Million
Q1 2022 May 12, 2022	BUY	$26.68 - $34.81 $2.6 Million - $3.4 Million	97,587 Added 11.34%	957,930 $27.9 Million
Q4 2021 Feb 09, 2022	BUY	$29.58 - $49.78 $1.77 Million - $2.98 Million	59,929 Added 7.49%	860,343 $28.3 Million
Q3 2021 Nov 08, 2021	SELL	$41.92 - $58.18 $186,376 - $258,668	-4,446 Reduced 0.55%	800,414 $36.9 Million
Q2 2021 Aug 05, 2021	BUY	$52.06 - $61.27 $661,578 - $778,619	12,708 Added 1.6%	804,860 $44.4 Million
Q1 2021 May 05, 2021	BUY	$44.23 - $57.5 $3.36 Million - $4.37 Million	76,074 Added 10.62%	792,152 $40.9 Million
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $10.2 Million - $14.2 Million	305,856 Added 74.56%	716,078 $31 Million
Q3 2020 Nov 09, 2020	BUY	$33.87 - $55.93 $2.05 Million - $3.38 Million	60,514 Added 17.3%	410,222 $14.4 Million
Q2 2020 Aug 04, 2020	SELL	$34.45 - $53.48 $2.41 Million - $3.74 Million	-69,890 Reduced 16.66%	349,708 $18.7 Million
Q1 2020 May 12, 2020	SELL	$31.52 - $53.81 $1.32 Million - $2.25 Million	-41,904 Reduced 9.08%	419,598 $14.9 Million
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $3.18 Million - $5.35 Million	105,712 Added 29.71%	461,502 $22 Million
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $1.32 Million - $2.02 Million	40,663 Added 12.9%	355,790 $11.5 Million
Q2 2019 Aug 02, 2019	BUY	$46.17 - $68.1 $1.51 Million - $2.23 Million	32,782 Added 11.61%	315,127 $15.7 Million
Q1 2019 Apr 26, 2019	BUY	$45.92 - $67.67 $4.21 Million - $6.21 Million	91,696 Added 48.1%	282,345 $19 Million
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $2.55 Million - $4.57 Million	-59,774 Reduced 23.87%	190,649 $8.64 Million
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $3.49 Million - $4.47 Million	48,631 Added 24.1%	250,423 $19.3 Million
Q2 2018 Aug 01, 2018	BUY	$73.22 - $99.55 $2.5 Million - $3.39 Million	34,101 Added 20.34%	201,792 $17 Million
Q1 2018 May 07, 2018	SELL	$59.83 - $86.53 $5.05 Million - $7.31 Million	-84,469 Reduced 33.5%	167,691 $13.7 Million
Q4 2017 Feb 01, 2018	SELL	$52.12 - $72.33 $204,623 - $283,967	-3,926 Reduced 1.53%	252,160 $14.4 Million
Q3 2017 Nov 02, 2017	BUY	$54.89 - $67.12 $14.1 Million - $17.2 Million	256,086	256,086 $17.1 Million

Others Institutions Holding AGIO

# of Institutions

207

Shares Held

60M

Call Options Held

365K

Put Options Held

457K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.36B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Agios Pharmaceuticals, Inc. Transaction History